跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23,104 条关于
“systemic pegcetacoplan”
全部
23,104
临床试验
18,564
药物
142
机构
228
资讯
4,170
去年
Apellis Secures $300 Million in Non-Dilutive Financing Through Sobi Royalty Agreement for Rare Kidney Disease Therapy
去年
Pegcetacoplan Shows Promise in Phase 3 VALIANT Study for Rare Kidney Diseases
去年
Pegcetacoplan Shows Promise in Phase 3 VALIANT Study for Rare Kidney Diseases
去年
Pegcetacoplan Shows Significant Treatment Effect in C3G and IC-MPGN Patients
去年
Pegcetacoplan Shows Strong Results in VALIANT Trial for C3G and IC-MPGN
去年
Pegcetacoplan Shows Strong Efficacy in C3G and IC-MPGN Patients: VALIANT Trial Results
去年
Pegcetacoplan Shows Promise in Treating Rare Kidney Diseases C3G and IC-MPGN
去年
Pegcetacoplan Shows Promise in C3 Glomerulopathy and IC-MPGN: VALIANT Trial Results
去年
EU Confirms Rejection of Apellis' Pegcetacoplan for Geographic Atrophy
去年
Pegcetacoplan Shows Promise in C3G and IC-MPGN Treatment: VALIANT Trial
第 1 页,共 417 页
上一页
下一页